Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappa B

Increased oxidative stress and subsequent activation of the transcription f actor NF-kappa B has been linked to the development of late diabetic compli cations. To determine whether oxidative stress dependent NF-kappa B activat ion is evident in patients with diabetic nephropathy we used an Electrophor etic Mobility Shift Assay based semiquantitative detection system which ena bled us to determine NF-kappa B activation in ex vivo isolated peripheral b lood mononuclear cells. We examined 33 patients with diabetes mellitus (Typ e I and Type II). Patients with diabetic nephropathy showed higher NF-kappa B binding activity in Electrophoretic Mobility Shift Assays and stronger i mmunohistological staining for activated NF-kappa Bp65 than patients withou t renal complications. NF-kappa B binding activity correlated with the degr ee of albuminuria (r = 0.316) and with thrombomodulin plasma concentrations (r = 0.33), indicative for albuminuria associated endothelial dysfunction. In a 3 day intervention study in which 600 mg of the antioxidant thioctic acid (alpha-lipoic acid) per day were given to nine patients with diabetic nephropathy oxidative stress in plasma samples was decreased by 48% and NF- kappa B binding activity in ex vivo isolated peripheral blood mononuclear c ells by 38%. In conclusion, activation of the transcription factor NF-kappa B in ex vivo isolated peripheral blood mononuclear cells of patients with diabetes mell itus correlates with the degree of diabetic nephropathy. NF-kappa B activat ion is at least in part dependent on oxidative stress since thioctic acid ( alpha-lipoic acid) reduced NF-kappa B binding activity.